Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher rates of toxicities. A reduced radiation dose may be safe, tolerable and/or effective compared to standard of care radiation dose in treating patients with indolent non-Hodgkin lymphoma.
Epistemonikos ID: abd1a9d4e5b23c3bc8b301044ca8d1095e716ac3
First added on: May 16, 2024